# | ||||
---|---|---|---|---|
1 | IB4SD-TRISTAN Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 | 22˙641˙050.00 | 12˙000˙000.00 |
2 | IMMUCAN Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 | 34˙937˙500.00 | 17˙830˙000.00 |
The Institution EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL has been involved also in the following Horizon 2020 projects.